Sign in

CIK 0001649989

  • Non-accelerated filer
  • Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
383982704
Phone
+1 609-619-3990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-11-07 BioLexis Pte Ltd. Director Grant or award +8,577,248 $0.93 $8.0M 52,904,631
2018-10-22 Bahrt Kenneth Chief Medical Officer Grant or award · Stock Option (Right to Buy) +450,000 450,000
2018-10-22 MCANDREW STEPHEN J SVP Bus. Strat. & Dev. Grant or award · Stock Option (Right to Buy) +200,000 200,000
2018-09-30 BioLexis Pte Ltd. Director Other acquisition · Series A-1 Convertible Preferred Stock +1,468 60,203
2018-09-30 BioLexis Pte Ltd. 10% owner Other acquisition · Series A-1 Convertible Preferred Stock +1,648 60,383
2018-09-21 THURMAN RANDY H Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2018-09-21 HILZINGER KURT J Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2018-09-21 Windisch Joerg Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2018-09-21 Mohan Pankaj Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2018-09-18 KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy Sale −10,100 $0.87 $9K 57,213
2018-08-01 KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy Grant or award · Stock Option (Right to Buy) +500,000 500,000
2018-07-18 GMS Tenshi Holdings Pte. Ltd Director Grant or award · Series A Convertible Preferred Stock +6,526 58,735
2018-07-18 GMS Tenshi Holdings Pte. Ltd Director Returned to the company · Series A Convertible Preferred Stock −58,735 0
2018-07-18 GMS Tenshi Holdings Pte. Ltd Director Grant or award · Series A-1 Convertible Preferred Stock +58,735 58,735
2018-06-27 THURMAN RANDY H Director Grant or award · Stock Option (Right to Buy) +100,000 100,000
2018-06-25 Bahrt Kenneth Chief Medical Officer Sale −7,700 $0.85 $7K 47,120
2018-06-20 GMS Tenshi Holdings Pte. Ltd Director Conversion +31,572,617 44,327,383
2018-06-20 GMS Tenshi Holdings Pte. Ltd Director Conversion · Series A Convertible Preferred Stock −208,836 52,209
2018-06-15 MCANDREW STEPHEN J SVP Bus. Strat. & Dev. Grant or award · Stock Option (Right to Buy) +30,000 30,000
2018-06-08 GMS Tenshi Holdings Pte. Ltd Director Grant or award +6,377,383 $0.98 $6.2M 12,754,766

Page 16 of 20 · 386 trades